KSHB: Saint Luke's Leads Groundbreaking AFib Treatment

Atrial Fibrillation, or Afib, is the most common type of heart arrhythmia and the number of people diagnosed with AFib is increasing both in the United States and globally.

Saint Luke’s Mid America Heart Institute cardiologists were the first in Kansas and Missouri to participate in a clinical trial for a novel treatment of AFib known as "pulse field ablation."

Dr. Sanjaya Gupta spoke to KSHB about this groundbreaking treatment, as well as the second Saint Luke's patient to undergo pulse field ablation.

Watch the full KSHB story: Saint Luke’s Helps Lead Groundbreaking Clinical Trial for Afib Treatment.

Related Content

Nov. 15, 2024

Health News You Can Use: Saint Luke’s Muriel I. Kauffman Institute for Women’s Cardiovascular Research
The new Saint Luke’s Muriel I. Kauffman Institute for Women’s Cardiovascular Research is the first of its kind dedicated to studying unique aspects of heart conditions in women.
Thumbnail
Aug. 16, 2012

Learn More About Our AFib Research Study
AFib occurs when the heart beats irregularly or too fast and can increase the risk for stroke and heart failure. Learn more about our AFib research studies.